Catalogo dei prodotti della ricerca

GRADILONE, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.385
EU - Europa 1.224
AS - Asia 676
SA - Sud America 38
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.352
IT - Italia 399
SG - Singapore 265
SE - Svezia 211
DE - Germania 206
IN - India 204
CN - Cina 154
FI - Finlandia 119
UA - Ucraina 76
GB - Regno Unito 53
AR - Argentina 33
RU - Federazione Russa 33
CA - Canada 29
BG - Bulgaria 26
TG - Togo 24
ID - Indonesia 20
BE - Belgio 18
IE - Irlanda 18
FR - Francia 17
RO - Romania 12
NL - Olanda 7
CH - Svizzera 6
HK - Hong Kong 6
IR - Iran 4
LT - Lituania 4
EU - Europa 3
GR - Grecia 3
JP - Giappone 3
MX - Messico 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BR - Brasile 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
ES - Italia 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
PL - Polonia 2
SA - Arabia Saudita 2
VN - Vietnam 2
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GL - Groenlandia 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
Totale 6.358
Salva come PNG Salva come JPEG
Città #
Fairfield 701
Chandler 406
Woodbridge 355
Ashburn 344
Seattle 264
Houston 261
Cambridge 232
Ann Arbor 226
Wilmington 191
Singapore 180
Rome 147
Princeton 109
Grafing 104
San Paolo di Civitate 92
Dearborn 89
Plano 89
Lawrence 81
Boston 59
Beijing 58
Des Moines 56
Santa Clara 50
San Diego 42
Millbury 38
Helsinki 37
New York 32
Federal 31
Fremont 28
Boardman 27
Andover 26
Jacksonville 26
Sofia 25
Lomé 24
Bremen 21
Toronto 20
Jakarta 19
Dublin 18
Kunming 18
Brussels 17
Norwalk 15
Falls Church 14
Hefei 14
London 14
Moscow 14
Los Angeles 12
Bühl 10
Falkenstein 10
Guangzhou 10
Nanjing 8
Ottawa 8
Phoenix 8
Hong Kong 6
Milan 6
Munich 6
San Mateo 6
Stockholm 6
Bern 5
Frankfurt am Main 5
Mannheim 5
Palermo 5
Paris 5
Southend 5
Caserta 4
Indiana 4
Latina 4
Montesilvano Marina 4
Priverno 4
Redmond 4
Arezzo 3
Auburn Hills 3
Nanchang 3
Pune 3
Redwood City 3
Shanghai 3
Zhengzhou 3
Amsterdam 2
Argenta 2
Ariccia 2
Aversa 2
Bari 2
Benevento 2
Canterbury 2
Castegnero 2
Centrale 2
Chengdu 2
Edinburgh 2
Foggia 2
Formello 2
Frosinone 2
Genoa 2
Groningen 2
Gunzenhausen 2
Hangzhou 2
Italy 2
Kilburn 2
Laurel 2
Leawood 2
Malmesbury 2
Muizenberg 2
Naples 2
San Cesareo 2
Totale 4.837
Salva come PNG Salva come JPEG
Nome #
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 118
A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer 116
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 113
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 105
Prevalence of human papillomavirus, cytomegalovirus, and Epstein-Barr virus in the cervix of healthy women 101
Circulating tumor cells identify patients with super-high-risk non-muscle-invasive bladder cancer: updated outcome analysis of a prospective single-center trial 101
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 97
Circulating tumor cells in right-and left-sided colorectal cancer 95
Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer 93
Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors 92
EpCAM expressing circulating tumor cells in colorectal cancer 91
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 90
CIRCULATING TUMOR CELLS AND THEIR PROGNOSTICSIGNIFICANCE IN NON MUSCLE INVASIVE BLADDER CANCER:A CELLSEARCH ANALYSIS. 89
Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders 88
Prognostic role of circulating tumor cell trajectories in metastatic colorectal cancer 87
Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data 86
High frequency of human papillomavirus detection in urinary bladder cancer 86
Circulating tumor cells count and characterization in a male breast cancer patient 85
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 85
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. 85
Detection of CK 19, CK 20 and EGFR mRNAs in peripheral blood of carcinoma patients : correlation with clinical stage of disease. 84
Celecoxib induces MRP-4 in lung cancer cells: Therapeutic implications 84
Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer 82
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? 80
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 80
BAX gene expression in melanoma metastases 80
Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: Correlation with local relapses 79
Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma 79
Detection of BCL-2 RNA in low grade tumours of the urinary bladder 78
HTLV-I AND HIV-1 INFECTION IN PATIENTS WITH LYMPHADENOPATHY SYNDROME DETECTED DURING ROUTINE BREAST SCREENING AT A TUMOR PREVENTION CENTER 78
Erythropoietin expression in primary rat Sertoli and peritubular myoid cells 77
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 77
HTLV-I and HIV infection in drug addicts in Italy. 76
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 76
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. 75
Chemoresistance profile of circulating tumor cells: Toward a clinical benefit? 75
HTLV-I is endemic in southern Italy: Detection of the first infectious cluster in a white population 74
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 74
Celecoxib upregulates multidrug resistance proteins in colon cancer: Lack of synergy with standard chemotherapy 73
Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. 73
Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients 72
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 72
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients 71
Comment on: isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties 70
Circulating tumor cells in high-risk nonmetastatic colorectal cancer 69
Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” 69
Tyrosinase Expression as a Molecular Marker for Investigating the Presence of Circulating Tumor Cells in Melanoma Patients 68
Circulating Tumor Cells in Cancer Therapy: Are we off Target? 67
Significance of Circulating Tumor Cells in Soft Tissue Sarcoma 67
Involvment of bcl-2 and bax gene expression in apoptosis and differentiation of the non-tumorigenic murine hematopoietic cell line, 32DCl3(G). 66
Circulating tumor cells: Exploring intratumor heterogeneity of colorectal cancer 66
Lichenoid dermatitis with scarring and white spot disease: a simple co-occurrence? 65
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 64
Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer 64
p53, gp170 and K 19 as clinical prognostic factors for response in head and neck squamous cell carcinoma 64
Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL). 62
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer 61
Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast 60
HIGH-FREQUENCY OF EPSTEIN-BARR VIRUS GENOME IN HIV-POSITIVE PATIENTS WITH HODGKINS-DISEASE 60
A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases 60
Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer 59
Variable levels of bcl-2, bcl-X and bax mRNA in bladder cancer progression 58
EpCAMlow circulating tumor cells: Gold in the waste 57
High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. 57
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 56
Detection of human papillomavirus type 16 DNA sequences in paraffin-embedded tissues from the female urinary tract 54
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 54
The increasing use of intravescical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. 53
Tenascin C: A defensive role in sentinel lymph nodes of melanoma patients? 53
Prevalence of Papillomavirus, Epstein-Barr virus, cytomegalovirus and herpes simplex virus type 2 in urinary bladder cancer. 53
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 52
Prognostic significance of survivin-expressing tumor cells in T1G3 bladder cancer 51
Morbidity of selective lymph node biopsy for melanoma: meta-analysis of complications 51
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 51
Detection of circulating tumor cells in patients with laryngeal cancer using screencell: comparative pre- and post-operative analysis and association with prognosis 51
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test 51
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. 51
Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 50
How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment. 50
Controversies in circulating tumor cell count during therapy 48
ABCB5 in peripheral blood of a patient affected by multiple primary malignancies 47
Epidermal growth factor receptor (EGFR) mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure 45
Circulating tumor cells: highlight on practical implications. 43
Human T-cell leukemia/lymphoma virus (HTLV I) DNA: detection in Italy in a lymphoma and in a Kaposi sarcoma patient. 41
Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo. 41
Circulating tumor cells in early bladder cancer: insight into micrometastatic disease 41
Survivin expression in sentinel lymph nodes from melanoma patients - In reply 40
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma. 39
High levels of transforming growth factor-alpha (TGF-alpha) mRNA may predict local relapses in early stage urinary bladder cancer. 39
Post-transfusional human retrovirus infection in 41 Italian beta-thalassemic patients. 39
Circulating tumor cells isolation: The “post-EpCAM era” 37
Detection of epidermal growth factor receptor mRNA in peripheral blood: A new marker of circulating neoplastic cells in bladder cancer patients 37
Failure of apoptosis and activation on NF kappa B by celecoxib and aspirin in lung cancer cell lines 35
null 35
Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions. 35
Biologia molecolare 34
PROGNOSTIC VALUE OF CIRCULATING TUMOR CELLS IN PATIENTS WITH METASTATIC BREAST CANCER AND METASTATIC PROSTATE CANCER 29
null 23
Circulating tumor cells in young and elderly patients with colorectal cancer: "lupus et agnus". 22
Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: Prognostic significance 21
Totale 6.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020988 0 0 0 0 0 205 238 160 159 114 66 46
2020/2021614 54 61 37 33 23 53 4 36 64 204 42 3
2021/20221.136 13 65 112 49 135 23 37 116 82 87 225 192
2022/20231.314 215 299 75 174 136 159 30 56 95 12 50 13
2023/2024567 33 82 20 49 42 79 14 73 5 83 36 51
2024/2025414 45 66 75 73 67 88 0 0 0 0 0 0
Totale 6.594